BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26209187)

  • 1. Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes.
    Nakagawa Y; Negishi Y; Shimizu M; Takahashi M; Ichikawa M; Takahashi H
    Immunol Lett; 2015 Oct; 167(2):72-86. PubMed ID: 26209187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 increases proliferation and interferon-gamma production but not cytolytic activity of human antigen-specific effector memory cytotoxic T lymphocytes: power of the effect depends on the functional avidity of the T cell and the antigen concentration.
    Bontkes HJ; Ruizendaal JJ; Kramer D; Meijer CJ; Schreurs MW; Hooijberg E
    Hum Immunol; 2005 Nov; 66(11):1137-45. PubMed ID: 16571414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II.
    Maeda A; Okazaki T; Inoue M; Kitazono T; Yamasaki M; Lemonnier FA; Ozaki S
    Int Immunopharmacol; 2009 Sep; 9(10):1183-8. PubMed ID: 19540938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
    Lin X; Pease LR; Murray PD; Rodriguez M
    J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of antigen delivery route in vivo and imune-boosting effects mediated by pH-sensitive liposomes encapsulated with K(b)-restricted CTL epitope.
    Lee KY; Chun E; Seong BL
    Biochem Biophys Res Commun; 2002 Apr; 292(3):682-8. PubMed ID: 11922620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
    Barsoum IB; Smallwood CA; Siemens DR; Graham CH
    Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes.
    Alatrash G; Qiao N; Zhang M; Zope M; Perakis AA; Sukhumalchandra P; Philips AV; Garber HR; Kerros C; St John LS; Khouri MR; Khong H; Clise-Dwyer K; Miller LP; Wolpe S; Overwijk WW; Molldrem JJ; Ma Q; Shpall EJ; Mittendorf EA
    Clin Cancer Res; 2019 Apr; 25(8):2610-2620. PubMed ID: 30647079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
    Mayrand SM; Healy PA; Torbett BE; Green WR
    Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
    Gullo CA; Esser MT; Fuller CL; Lam Braciale V
    J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
    Alexander-Miller MA; Leggatt GR; Berzofsky JA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4102-7. PubMed ID: 8633023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation.
    Mempel TR; Pittet MJ; Khazaie K; Weninger W; Weissleder R; von Boehmer H; von Andrian UH
    Immunity; 2006 Jul; 25(1):129-41. PubMed ID: 16860762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of cytotoxic T cells and tumor regression by soluble antigen formulation.
    Hariharan K; Braslawsky G; Black A; Raychaudhuri S; Hanna N
    Cancer Res; 1995 Aug; 55(16):3486-9. PubMed ID: 7627951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis of epitope-specific antiretroviral cytotoxic T lymphocytes via Fas ligand-Fas interactions.
    Rich RF; Green WR
    Viral Immunol; 2006; 19(3):424-33. PubMed ID: 16987061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
    Bae J; Martinson JA; Klingemann HG
    Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs.
    Correale P; Del Vecchio MT; La Placa M; Montagnani F; Di Genova G; Savellini GG; Terrosi C; Mannucci S; Giorgi G; Francini G; Cusi MG
    J Immunother; 2008; 31(2):132-47. PubMed ID: 18481383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell.
    Gao FG; Khammanivong V; Liu WJ; Leggatt GR; Frazer IH; Fernando GJ
    Cancer Res; 2002 Nov; 62(22):6438-41. PubMed ID: 12438231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Analyses Reveal How Hypoxia Reconfigures the Proteome of Primary Cytotoxic T Lymphocytes.
    Ross SH; Rollings CM; Cantrell DA
    Front Immunol; 2021; 12():712402. PubMed ID: 34603285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.